N-(2-chloro-5-methylphenyl)-4-[3-(thiophen-2-ylmethylcarbamoyl)-2-pyridinyl]piperazine-1-carboxamide
C23H24ClN5O2S — CID 91634438
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-chloro-5-methylphenyl)-4-[3-(thiophen-2-ylmethylcarbamoyl)-2-pyridinyl]piperazine-1-carboxamide
N-(2-chloro-5-methylphenyl)-4-[3-(thiophen-2-ylmethylcarbamoyl)-2-pyridinyl]piperazine-1-carboxamide (PubChem CID 91634438) has the molecular formula C23H24ClN5O2S and a molecular weight of 470.00 g/mol. Its IUPAC name is N-(2-chloro-5-methylphenyl)-4-[3-(thiophen-2-ylmethylcarbamoyl)-2-pyridinyl]piperazine-1-carboxamide.
Molecular Properties
| Compound Name | N-(2-chloro-5-methylphenyl)-4-[3-(thiophen-2-ylmethylcarbamoyl)-2-pyridinyl]piperazine-1-carboxamide |
|---|---|
| PubChem CID | 91634438 |
| Molecular Formula | C23H24ClN5O2S |
| Molecular Weight | 470.00 g/mol |
| Exact Mass | 469.13 |
| IUPAC Name | N-(2-chloro-5-methylphenyl)-4-[3-(thiophen-2-ylmethylcarbamoyl)-2-pyridinyl]piperazine-1-carboxamide |
| SMILES | Cc1ccc(Cl)c(NC(=O)N2CCN(c3ncccc3C(=O)NCc3cccs3)CC2)c1 |
| InChI | InChI=1S/C23H24ClN5O2S/c1-16-6-7-19(24)20(14-16)27-23(31)29-11-9-28(10-12-29)21-18(5-2-8-25-21)22(30)26-15-17-4-3-13-32-17/h2-8,13-14H,9-12,15H2,1H3,(H,26,30)(H,27,31) |
| InChIKey | OUYAPPZOUSHJRL-UHFFFAOYSA-N |
| XLogP | 4.39 |
| TPSA | 77.57 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 470.00 |
| LogP ≤ 5 | 4.39 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91634438 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.